Clinically unrecognized Q-wave mycocardial infarction in patients with diabetes mellitus, systemic hypertension, and nephropathy

被引：18

作者：

Aguilar, D

Goldhaber, SZ

Gans, DJ

Levey, AS

Porush, JG

Lewis, JB

Rouleau, JL

Berl, T

Lewis, EJ

Pfeffer, MA

机构：

[1] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA

[2] Bristol Myers Squibb Pharmaceut Res Inst, Pennington, NJ USA

[3] Tufts Univ New England Med Ctr, Boston, MA USA

[4] Brookdale Univ Hosp, Brooklyn, NY USA

[5] Ctr Med, Brooklyn, NY USA

[6] Vanderbilt Univ, Coll Med, Nashville, TN USA

[7] Univ Montreal, Montreal, PQ, Canada

[8] Univ Colorado, Sch Med, Denver, CO 80202 USA

[9] Rush Presbyterian St Lukes Med Ctr, Chicago, IL 60612 USA

[10] Univ Texas, Hlth Sci Ctr, Div Cardiol, Houston, TX USA

来源：

AMERICAN JOURNAL OF CARDIOLOGY | 2004年 / 94卷 / 03期

关键词：

D O I：

10.1016/j.amjcard.2004.04.028

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

During the Irbesartan Diabetic Nephropathy Trial, 1,387 participants with type 2 diabetes mellitus, hypertension, and nephropathy underwent serial electrocardiograms for the identification of Q-wave myocardial infarction (MI). During a mean follow-up of 2.5 years, 14 of 99 first nonfatal MIs in this group were clinically unrecognized, accounting for 14% of all first nonfatal MIs. (C) 2004 by Excerpta Medica, Inc.

引用

页码：337 / 339

页数：3

共 17 条

[11] PREVALENCE, INCIDENCE AND PROGNOSIS OF RECOGNIZED AND UNRECOGNIZED MYOCARDIAL-INFARCTION IN PERSONS AGED 75 YEARS OR OLDER - THE BRONX AGING STUDY [J].